Scientists crack rabies virus weaponry

November 12, 2019

Researchers have found a way to stop the rabies virus shutting down the body's immune defence against it. In doing so they have solved a key scientific puzzle and have laid the foundation for the development of new anti-rabies vaccines.

Rabies kills an estimated 60,000 people a year, most of them in developing countries, overwhelmingly through dog bites.

Monash University Dr Greg Moseley, from the Monash Biomedicine Discovery Institute (BDI), and University of Melbourne Associate Professor Paul Gooley, from the Bio21 Institute were senior authors in the study, published in Cell Reports.

"It's been known for a long time that many viruses target the human protein STAT1 and related proteins to shut down the host's immune defences, and it's also assumed that this is very important for diseases," long-term rabies researcher Dr Moseley said.

However, it was not known exactly how P-protein ­- the main 'immune antagonist' of lyssaviruses including the rabies virus - takes hold of STAT1, due to a lack of direct structural data on STAT1 complexes with viral proteins.

"The challenge was to produce the key proteins on the viral and host sides in a test tube and keep them stable so we could interrogate the interaction directly; this hadn't been done before, at least for the full-size human protein," Dr Moseley said.

The researchers then brought the two proteins together and, using nuclear magnetic resonance spectroscopy, showed the precise regions where the viral protein sticks onto STAT1 and holds onto it to keep it away from locations in the cell where it needs to be to activate the immune response.

"We were able to find new regions and new sites for mutations and so could target these in a virus, completely preventing it from being able to grab hold of STAT1," Associate Professor Gooley, an expert in nuclear magnetic resonance spectroscopy, said.

To the researchers' knowledge, this was the first direct structural analysis of binding of full sized STAT1 to a viral protein, even though many viruses such as measles and Hendra target this protein.

Using a 'wild' strain of rabies virus, collaborators at the Pasteur Institute in France showed that by disabling this binding they could strongly weaken even a highly pathogenic virus.

The findings of their five-year study are the subject of a recently lodged international patent.

A global drive is underway to find better ways to counter rabies, which is caused by the rabies virus and also other lyssaviruses including an Australian bat virus.

Methods such as culling dogs have not worked to control rabies and while mass vaccination is effective, catching and injecting animals is problematic.

"The development of a new safe and highly effective rabies vaccine that can be given orally or as 'baits' would be a major step forward," Dr Moseley said.

Associate Professor Gooley said he is excited to have been involved in a project that could lead to a safer oral vaccine for rabies to eliminate it, especially in developing countries.

"Like Greg I'm a discovery scientist, driven by curiosity. I enjoy solving scientific problems," Associate Professor Gooley said.

"The state-of-the-art technological tools and methods used in the study could also be applied more broadly to counter other viruses that target STAT proteins."
First author on the paper was then PhD student Dr Alamgir Hossain.

The study was supported by grants including from the Australian National Health & Medical Research Council Australia, Australian Research Council and Grimwade Fellowship, Miegunyah Fund.

University of Melbourne

Related Proteins Articles from Brightsurf:

New understanding of how proteins operate
A ground-breaking discovery by Centenary Institute scientists has provided new understanding as to the nature of proteins and how they exist and operate in the human body.

Finding a handle to bag the right proteins
A method that lights up tags attached to selected proteins can help to purify the proteins from a mixed protein pool.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

New method to monitor Alzheimer's proteins
IBS-CINAP research team has reported a new method to identify the aggregation state of amyloid beta (Aβ) proteins in solution.

Composing new proteins with artificial intelligence
Scientists have long studied how to improve proteins or design new ones.

Hero proteins are here to save other proteins
Researchers at the University of Tokyo have discovered a new group of proteins, remarkable for their unusual shape and abilities to protect against protein clumps associated with neurodegenerative diseases in lab experiments.

Designer proteins
David Baker, Professor of Biochemistry at the University of Washington to speak at the AAAS 2020 session, 'Synthetic Biology: Digital Design of Living Systems.' Prof.

Gone fishin' -- for proteins
Casting lines into human cells to snag proteins, a team of Montreal researchers has solved a 20-year-old mystery of cell biology.

Coupled proteins
Researchers from Heidelberg University and Sendai University in Japan used new biotechnological methods to study how human cells react to and further process external signals.

Understanding the power of honey through its proteins
Honey is a culinary staple that can be found in kitchens around the world.

Read More: Proteins News and Proteins Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to